APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharma and Health Care

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

Selected research

Industry Growth & Trends

Global Pharma and Health Care Industry Growth and Trends Forecast to 2032

30 December 2025120 pages

Choose your research edition.

Industry ResearchPharma and Health Care Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma and Health Care Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharma and Health Care Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma and Health Care Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma and Health Care Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

Read the full market overview

According to APO Research, the global Pharma and Health Care market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

This report provides a structured, data-driven view of the global Pharma and Health Care market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharma and Health Care market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma and Health Care market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma and Health Care.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharma and Health Care market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharma and Health Care Market by Company

Johnson & Johnson

Novartis

Roche

AbbVie

Merck & Co.

Bristol Myers Squibb

GlaxoSmithKline

Pfizer

Sanofi

Takeda

AstraZeneca

Bayer

Eli Lilly & Co.

Gilead Sciences

Amgen

Novo Nordisk

Teva

Boehringer Ingelheim

Biogen

Astellas

Pharma and Health Care Segment by Format

Bottle

Blister

Others

Pharma and Health Care Segment by Prescription

OTC Drugs

Prescription Drugs

Pharma and Health Care Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharma and Health Care companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharma and Health Care Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharma and Health Care Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharma and Health Care Market Share by Region (2021-2026) Table 4. Global Pharma and Health Care Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharma and Health Care Market Share by Region (2027-2032) Table 6. Global Pharma and Health Care Market Size by Format (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharma and Health Care Market Size by Format (2021-2026) & (US$ Million) Table 8. Global Pharma and Health Care Market Size Share by Format (2021-2026) Table 9. Global Pharma and Health Care Market Size Forecasted by Format (2027-2032) & (US$ Million) Table 10. Global Pharma and Health Care Market Size Share Forecasted by Format (2027-2032) Table 11. North America Pharma and Health Care Market Size Breakdown by Format (2021-2026) & (US$ Million) Table 12. North America Pharma and Health Care Market Size Breakdown by Format (2027-2032) & (US$ Million) Table 13. Europe Pharma and Health Care Market Size Breakdown by Format (2021-2026) & (US$ Million) Table 14. Europe Pharma and Health Care Market Size Breakdown by Format (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharma and Health Care Market Size Breakdown by Format (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharma and Health Care Market Size Breakdown by Format (2027-2032) & (US$ Million) Table 17. Latin America Pharma and Health Care Market Size Breakdown by Format (2021-2026) & (US$ Million) Table 18. Latin America Pharma and Health Care Market Size Breakdown by Format (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharma and Health Care Market Size Breakdown by Format (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharma and Health Care Market Size Breakdown by Format (2027-2032) & (US$ Million) Table 21. Global Pharma and Health Care Market Size by Prescription (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharma and Health Care Market Size by Prescription (2021-2026) & (US$ Million) Table 23. Global Pharma and Health Care Market Size Share by Prescription (2021-2026) Table 24. Global Pharma and Health Care Market Size Forecasted by Prescription (2027-2032) & (US$ Million) Table 25. Global Pharma and Health Care Market Size Share Forecasted by Prescription (2027-2032) Table 26. North America Pharma and Health Care Market Size Breakdown by Prescription (2021-2026) & (US$ Million) Table 27. North America Pharma and Health Care Market Size Breakdown by Prescription (2027-2032) & (US$ Million) Table 28. Europe Pharma and Health Care Market Size Breakdown by Prescription (2021-2026) & (US$ Million) Table 29. Europe Pharma and Health Care Market Size Breakdown by Prescription (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharma and Health Care Market Size Breakdown by Prescription (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharma and Health Care Market Size Breakdown by Prescription (2027-2032) & (US$ Million) Table 32. Latin America Pharma and Health Care Market Size Breakdown by Prescription (2021-2026) & (US$ Million) Table 33. Latin America Pharma and Health Care Market Size Breakdown by Prescription (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharma and Health Care Market Size Breakdown by Prescription (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharma and Health Care Market Size Breakdown by Prescription (2027-2032) & (US$ Million) Table 36. Pharma and Health Care Industry Trends Table 37. Pharma and Health Care Industry Drivers Table 38. Pharma and Health Care Industry Opportunities and Challenges Table 39. Pharma and Health Care Industry Restraints Table 40. Global Pharma and Health Care Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharma and Health Care Revenue Market Share by Company (2021-2026) Table 42. Global Pharma and Health Care Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharma and Health Care Key Company Headquarters & Area Served Table 44. Global Pharma and Health Care Company, Product Type & Application Table 45. Global Pharma and Health Care Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharma and Health Care by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Johnson & Johnson Pharma and Health Care Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis Pharma and Health Care Product Portfolio Table 57. Novartis Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Pharma and Health Care Product Portfolio Table 62. Roche Recent Development Table 63. AbbVie Company Information Table 64. AbbVie Business Overview Table 65. AbbVie Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AbbVie Pharma and Health Care Product Portfolio Table 67. AbbVie Recent Development Table 68. Merck & Co. Company Information Table 69. Merck & Co. Business Overview Table 70. Merck & Co. Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck & Co. Pharma and Health Care Product Portfolio Table 72. Merck & Co. Recent Development Table 73. Bristol Myers Squibb Company Information Table 74. Bristol Myers Squibb Business Overview Table 75. Bristol Myers Squibb Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bristol Myers Squibb Pharma and Health Care Product Portfolio Table 77. Bristol Myers Squibb Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Pharma and Health Care Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pfizer Pharma and Health Care Product Portfolio Table 87. Pfizer Recent Development Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sanofi Pharma and Health Care Product Portfolio Table 92. Sanofi Recent Development Table 93. Takeda Company Information Table 94. Takeda Business Overview Table 95. Takeda Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Takeda Pharma and Health Care Product Portfolio Table 97. Takeda Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AstraZeneca Pharma and Health Care Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Pharma and Health Care Product Portfolio Table 107. Bayer Recent Development Table 108. Eli Lilly & Co. Company Information Table 109. Eli Lilly & Co. Business Overview Table 110. Eli Lilly & Co. Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Eli Lilly & Co. Pharma and Health Care Product Portfolio Table 112. Eli Lilly & Co. Recent Development Table 113. Gilead Sciences Company Information Table 114. Gilead Sciences Business Overview Table 115. Gilead Sciences Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Gilead Sciences Pharma and Health Care Product Portfolio Table 117. Gilead Sciences Recent Development Table 118. Amgen Company Information Table 119. Amgen Business Overview Table 120. Amgen Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Amgen Pharma and Health Care Product Portfolio Table 122. Amgen Recent Development Table 123. Novo Nordisk Company Information Table 124. Novo Nordisk Business Overview Table 125. Novo Nordisk Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Novo Nordisk Pharma and Health Care Product Portfolio Table 127. Novo Nordisk Recent Development Table 128. Teva Company Information Table 129. Teva Business Overview Table 130. Teva Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Teva Pharma and Health Care Product Portfolio Table 132. Teva Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Pharma and Health Care Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. Biogen Company Information Table 139. Biogen Business Overview Table 140. Biogen Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Biogen Pharma and Health Care Product Portfolio Table 142. Biogen Recent Development Table 143. Astellas Company Information Table 144. Astellas Business Overview Table 145. Astellas Pharma and Health Care Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Astellas Pharma and Health Care Product Portfolio Table 147. Astellas Recent Development Table 148. North America Pharma and Health Care Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Pharma and Health Care Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Pharma and Health Care Market Share by Country (2021-2026) Table 151. North America Pharma and Health Care Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Pharma and Health Care Market Share Forecast by Country (2027-2032) Table 153. Europe Pharma and Health Care Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Pharma and Health Care Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Pharma and Health Care Market Share by Country (2021-2026) Table 156. Europe Pharma and Health Care Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Pharma and Health Care Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Pharma and Health Care Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Pharma and Health Care Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Pharma and Health Care Market Share by Country (2021-2026) Table 161. Asia-Pacific Pharma and Health Care Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Pharma and Health Care Market Share Forecast by Country (2027-2032) Table 163. Latin America Pharma and Health Care Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Pharma and Health Care Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Pharma and Health Care Market Share by Country (2021-2026) Table 166. Latin America Pharma and Health Care Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Pharma and Health Care Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Pharma and Health Care Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Pharma and Health Care Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Pharma and Health Care Market Share by Country (2021-2026) Table 171. Middle East & Africa Pharma and Health Care Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Pharma and Health Care Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharma and Health Care Product Image Figure 3. Global Pharma and Health Care Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharma and Health Care Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharma and Health Care Market Share by Region: 2025 VS 2032 Figure 6. Global Pharma and Health Care Market Share by Region (2021-2032) Figure 7. North America Pharma and Health Care Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharma and Health Care Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharma and Health Care Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharma and Health Care Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharma and Health Care Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Bottle Image Figure 13. Global Bottle Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Blister Image Figure 15. Global Blister Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Pharma and Health Care Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Pharma and Health Care Market Share by Type 2025 VS 2032 Figure 20. North America Pharma and Health Care Market Size Share by Type (2021-2032) Figure 21. Europe Pharma and Health Care Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Pharma and Health Care Market Size Share by Type (2021-2032) Figure 23. Latin America Pharma and Health Care Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Pharma and Health Care Market Size Share by Type (2021-2032) Figure 25. OTC Drugs Image Figure 26. Global OTC Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Prescription Drugs Image Figure 28. Global Prescription Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Pharma and Health Care Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pharma and Health Care Market Share by Application 2025 VS 2032 Figure 31. North America Pharma and Health Care Market Size Share by Application (2021-2032) Figure 32. Europe Pharma and Health Care Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Pharma and Health Care Market Size Share by Application (2021-2032) Figure 34. Latin America Pharma and Health Care Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Pharma and Health Care Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Pharma and Health Care Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Pharma and Health Care Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Pharma and Health Care Market Share by Country (2021-2032) Figure 41. Europe Pharma and Health Care Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Pharma and Health Care Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Pharma and Health Care Market Share by Country (2021-2032) Figure 44. Asia-Pacific Pharma and Health Care Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Pharma and Health Care Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Pharma and Health Care Market Share by Country (2021-2032) Figure 47. Latin America Pharma and Health Care Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Pharma and Health Care Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Pharma and Health Care Market Share by Country (2021-2032) Figure 50. Middle East & Africa Pharma and Health Care Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Pharma and Health Care Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Pharma and Health Care Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Bottle
  • Blister
  • Others
Applications
  • OTC Drugs
  • Prescription Drugs
Companies covered
  • Johnson & Johnson
  • Novartis
  • Roche
  • AbbVie
  • Merck & Co.
  • Bristol Myers Squibb
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Takeda
  • AstraZeneca
  • Bayer
  • Eli Lilly & Co.
  • Gilead Sciences
  • Amgen
  • Novo Nordisk
  • Teva
  • Boehringer Ingelheim
  • Biogen
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharma and Health Care Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharma and Health Care Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharma and Health Care Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharma and Health Care Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharma and Health Care Market Size (2021-2032)
  8. 1.5.1 North America Pharma and Health Care Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharma and Health Care Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharma and Health Care Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharma and Health Care Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharma and Health Care Market Size Growth Rate (2021-2032)
2 Pharma and Health Care Market by Format
  1. 2.1 Type Introduction
  2. 2.1.1 Bottle
  3. 2.1.2 Blister
  4. 2.1.3 Others
  5. 2.2 Global Pharma and Health Care Market Size by Format
  6. 2.2.1 Global Pharma and Health Care Market Size Overview by Format (2021-2032)
  7. 2.2.2 Global Pharma and Health Care Historic Market Size Review by Format (2021-2026)
  8. 2.2.3 Global Pharma and Health Care Market Size Forecasted by Format (2027-2032)
  9. 2.3 Global Pharma and Health Care Market Size by Regions
  10. 2.3.1 North America Pharma and Health Care Market Size Breakdown by Format (2021-2026)
  11. 2.3.2 Europe Pharma and Health Care Market Size Breakdown by Format (2021-2026)
  12. 2.3.3 Asia-Pacific Pharma and Health Care Market Size Breakdown by Format (2021-2026)
  13. 2.3.4 South America Pharma and Health Care Market Size Breakdown by Format (2021-2026)
  14. 2.3.5 Middle East and Africa Pharma and Health Care Market Size Breakdown by Format (2021-2026)
3 Pharma and Health Care Market by Prescription
  1. 3.1 Type Introduction
  2. 3.1.1 OTC Drugs
  3. 3.1.2 Prescription Drugs
  4. 3.2 Global Pharma and Health Care Market Size by Prescription
  5. 3.2.1 Global Pharma and Health Care Market Size Overview by Prescription (2021-2032)
  6. 3.2.2 Global Pharma and Health Care Historic Market Size Review by Prescription (2021-2026)
  7. 3.2.3 Global Pharma and Health Care Market Size Forecasted by Prescription (2027-2032)
  8. 3.3 Global Pharma and Health Care Market Size by Regions
  9. 3.3.1 North America Pharma and Health Care Market Size Breakdown by Prescription (2021-2026)
  10. 3.3.2 Europe Pharma and Health Care Market Size Breakdown by Prescription (2021-2026)
  11. 3.3.3 Asia-Pacific Pharma and Health Care Market Size Breakdown by Prescription (2021-2026)
  12. 3.3.4 South America Pharma and Health Care Market Size Breakdown by Prescription (2021-2026)
  13. 3.3.5 Middle East and Africa Pharma and Health Care Market Size Breakdown by Prescription (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharma and Health Care Industry Trends
  2. 4.2 Pharma and Health Care Industry Drivers
  3. 4.3 Pharma and Health Care Industry Opportunities and Challenges
  4. 4.4 Pharma and Health Care Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharma and Health Care Revenue (2021-2026)
  2. 5.2 Global Pharma and Health Care Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharma and Health Care Key Company Headquarters & Area Served
  4. 5.4 Global Pharma and Health Care Company, Product Type & Application
  5. 5.5 Global Pharma and Health Care Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharma and Health Care Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharma and Health Care Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Pharma and Health Care Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Pharma and Health Care Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Pharma and Health Care Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Pharma and Health Care Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Merck & Co.
  26. 6.5.1 Merck & Co. Company Information
  27. 6.5.2 Merck & Co. Business Overview
  28. 6.5.3 Merck & Co. Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co. Pharma and Health Care Product Portfolio
  30. 6.5.5 Merck & Co. Recent Developments
  31. 6.6 Bristol Myers Squibb
  32. 6.6.1 Bristol Myers Squibb Company Information
  33. 6.6.2 Bristol Myers Squibb Business Overview
  34. 6.6.3 Bristol Myers Squibb Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bristol Myers Squibb Pharma and Health Care Product Portfolio
  36. 6.6.5 Bristol Myers Squibb Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Pharma and Health Care Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Pharma and Health Care Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Pharma and Health Care Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Pharma and Health Care Product Portfolio
  60. 6.10.5 Takeda Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Pharma and Health Care Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Pharma and Health Care Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 Eli Lilly & Co.
  74. 6.13.1 Eli Lilly & Co. Company Information
  75. 6.13.2 Eli Lilly & Co. Business Overview
  76. 6.13.3 Eli Lilly & Co. Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Eli Lilly & Co. Pharma and Health Care Product Portfolio
  78. 6.13.5 Eli Lilly & Co. Recent Developments
  79. 6.14 Gilead Sciences
  80. 6.14.1 Gilead Sciences Company Information
  81. 6.14.2 Gilead Sciences Business Overview
  82. 6.14.3 Gilead Sciences Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Gilead Sciences Pharma and Health Care Product Portfolio
  84. 6.14.5 Gilead Sciences Recent Developments
  85. 6.15 Amgen
  86. 6.15.1 Amgen Company Information
  87. 6.15.2 Amgen Business Overview
  88. 6.15.3 Amgen Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Amgen Pharma and Health Care Product Portfolio
  90. 6.15.5 Amgen Recent Developments
  91. 6.16 Novo Nordisk
  92. 6.16.1 Novo Nordisk Company Information
  93. 6.16.2 Novo Nordisk Business Overview
  94. 6.16.3 Novo Nordisk Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Novo Nordisk Pharma and Health Care Product Portfolio
  96. 6.16.5 Novo Nordisk Recent Developments
  97. 6.17 Teva
  98. 6.17.1 Teva Company Information
  99. 6.17.2 Teva Business Overview
  100. 6.17.3 Teva Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Teva Pharma and Health Care Product Portfolio
  102. 6.17.5 Teva Recent Developments
  103. 6.18 Boehringer Ingelheim
  104. 6.18.1 Boehringer Ingelheim Company Information
  105. 6.18.2 Boehringer Ingelheim Business Overview
  106. 6.18.3 Boehringer Ingelheim Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Pharma and Health Care Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Recent Developments
  109. 6.19 Biogen
  110. 6.19.1 Biogen Company Information
  111. 6.19.2 Biogen Business Overview
  112. 6.19.3 Biogen Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Biogen Pharma and Health Care Product Portfolio
  114. 6.19.5 Biogen Recent Developments
  115. 6.20 Astellas
  116. 6.20.1 Astellas Company Information
  117. 6.20.2 Astellas Business Overview
  118. 6.20.3 Astellas Pharma and Health Care Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Astellas Pharma and Health Care Product Portfolio
  120. 6.20.5 Astellas Recent Developments
7 North America
  1. 7.1 North America Pharma and Health Care Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharma and Health Care Market Size by Country (2021-2026)
  3. 7.3 North America Pharma and Health Care Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharma and Health Care Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharma and Health Care Market Size by Country (2021-2026)
  3. 8.3 Europe Pharma and Health Care Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharma and Health Care Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharma and Health Care Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharma and Health Care Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharma and Health Care Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharma and Health Care Market Size by Country (2021-2026)
  3. 10.3 South America Pharma and Health Care Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharma and Health Care Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharma and Health Care Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharma and Health Care Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst